Loading clinical trials...
Loading clinical trials...
Dipyridamole Assessment for Flare Reduction in SLE
Conditions
Interventions
extended release dipyridamole 200mg/aspirin 25mg
81mg aspirin
Locations
1
United States
Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma, United States
Start Date
February 1, 2013
Primary Completion Date
May 1, 2017
Completion Date
November 1, 2017
Last Updated
November 25, 2020
NCT06647069
NCT07371468
NCT06333483
NCT07219563
NCT06875960
NCT07413341
Lead Sponsor
Oklahoma Medical Research Foundation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions